Volume 24 Issue 2
Volume 24 Issue 2
Bioengineering Animals
Apr-May 2011
Ethical Limits to Bioengineering Animals
By Paul Root Wolpe
Musical Genes
By CRG staff - interview with Greg Lukianoff
Sacred Ground
By Samuel W. Anderson
Food and Drug Amalgamation
By Eric Hoffman
Food Unchained
By Samuel W. Anderson
Goat Pharming
By CRG staff - interview with William Gavin of GTC Biotherapeutics
Back on "The Farm"
By Rob DeSalle
Gallery: Bioengineered Animals
By CRG Staff
Topic Update: Federal Circuit Hears Appeal in Myriad Gene Patent Case
By CRG Staff
SARS in the City
By Lynn C. Klotz
Gene Patenting in Canada
By James J. Rusthoven
Unnatural Selection
By CRG staff - interview with Mara Hvistendahl
Massachusetts Legislature Holds Hearing on Genetic Bill of Rights
By Jeremy Gruber
By Samuel W. Anderson
Search: GeneWatch
The use of forensic DNA databases by law enforcement around the globe is expanding at a rate that should be of great concern to civil libertarians.
View Project
Rapid developments in biotechnology over the last two decades have enabled corporations and scientists to alter nature's handiwork for commercial profit. The patent, a tool originally created to insure that inventors could share in the financial returns and benefits deriving from the use of their nventions, has become the primary mechanism through which the private sector advances its claims to ownership over genes, proteins, and entire organisms.
View Project